Business Context and Reporting Period
This Form 8-K is filed by Ekso Bionics Holdings, Inc. (not Chronoscale Holdings Corp as indicated in metadata) on December 8, 2017. The report addresses a significant change in the auditor's assessment of the company's internal controls over financial reporting as of December 31, 2016.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The document focuses exclusively on the status of internal controls and the auditor's opinion rather than operational financial performance.
Material Changes
- Material Weakness Identified: OUM & Co. LLP (the auditor) notified the company that its previous report on the effectiveness of internal controls as of December 31, 2016, should no longer be relied upon. A material weakness in information technology (IT) general controls was identified following a PCAOB inspection.
- Financial Statement Opinion: Despite the material weakness, OUM has reconfirmed its unqualified opinion on the fairness of the financial statements in the 2016 10-K after performing additional testing without reliance on internal controls.
- No Restatement: The material weakness has not resulted in a restatement of consolidated financial statements or footnote disclosures for periods through December 31, 2016.
Outlook, Management Commentary, and Risks
Management has concluded that internal control over financial reporting was not effective as of December 31, 2016, and disclosure controls were ineffective for subsequent interim periods. To address this, the company implemented a more robust accounting and enterprise resource planning system provided by Infor, which became operational in October 2017. The company plans to amend its 2016 10-K and 2017 10-Q filings to reflect the material weakness and the ineffectiveness of disclosure controls.
Investor Verification Checklist
- Verify the upcoming amended 10-K and 10-Q filings to confirm the formal disclosure of the material weakness.
- Review the specific details of the IT general control deficiencies identified by the auditor.
- Monitor the company's progress in remediation efforts following the implementation of the Infor system.
- Confirm that the unqualified opinion on financial statement fairness remains intact despite the control weakness.